- Rating
- 2
- Confidence
- 2
- Informativeness
- 2
- Presentation
- 2
- Soundness
- 2
Read review
Paper summary
This paper proposes a prediction-reasoning fusion framework for molecular hit discovery, combining an MLP ensemble for activity prediction with LLM-generated decision trees for compound selection. The LLM iteratively develops acquisition policies using molecular features, numerical summaries, and evaluation feedback, while the predictive model is retrained after each acquisition round. The authors also provide a theoretical analysis of how improvements in development utility may transfer to actual discovery performance. Experiments on HIV and ALDH1 benchmarks report improvements in hit discovery and early acquisition efficiency compared with MLP-based ranking and random-tree search, although development gains do not consistently translate into better acquisition outcomes.
Critical strengths
The paper presents an interesting integration of predictive modelling and LLM-guided policy optimisation for molecular hit discovery. A notable strength is the use of interpretable decision trees, which allows scientists to examine and understand compound selection strategies. The iterative evaluation and feedback mechanism provides a systematic approach to refining acquisition policies, while the theoretical analysis offers insight into the relationship between development utility and actual discovery performance. The comparisons with MLP ranking and random-tree search further support the potential effectiveness of the proposed framework.
Critical weaknesses
The experimental evaluation is limited to two molecular screening benchmarks, which restricts the evidence for generalisability across different chemical and biological settings. Although the proposed approach improves average hit discovery performance, higher development utility does not consistently translate into better acquisition outcomes, raising concerns about policy stability and reliability. Furthermore, the iterative LLM-guided search introduces additional computational complexity, but its efficiency and scalability are not sufficiently established. Broader experimental validation and a more detailed analysis of the contribution of LLM-guided reasoning would strengthen the paper.
Questions for authors
-
How consistently do improvements in development utility translate into better acquisition outcomes, and what factors contribute to cases where this relationship does not hold?
-
How much of the performance improvement can be attributed specifically to LLM-guided reasoning, rather than the decision-tree representation and iterative policy evaluation?
-
How well does the proposed framework scale to larger molecular libraries and more diverse screening tasks, particularly considering the computational cost of repeated LLM-guided policy searches?